3M Opens Lab in Singapore

3M Drug Delivery Systems has held an opening event for its laboratory site at its facility in Yishun. The event was attended by guest-of-honor Lim Hng Kiang, Singapore’s minister for Trade and Industry; as well as George Buckley, 3M chairman, president and CEO. The laboratory will develop products in both the inhalation and transdermal categories.

Currently, products developed by the Singapore laboratory will be suitable for manufacture in 3M’s worldwide network of manufacturing sites, or the customers’ own facilities, and will be developed in line with global standards. The 20,000sq ft facility is configured in a scalable design to enable it to expand when customer demand grows.

“This new site will help us provide Asia-Pacific customers with a product development service that has both local and global capabilities,” said Jim Vaughan, VP and GM, 3M Drug Delivery Systems Division. “Singapore’s excellent infrastructure and highly qualified workforce make it an ideal fit for our needs.”

“The new 3M Drug Delivery Systems Lab in Singapore also has the capacity and know-how to take unique formulations developed in the Asian region along the development path: from feasibility, development, manufacturing quality assurance as well as global regulatory expertise.” added Vaughan.